"New Antibody Therapy Shows Promise Against Aggressive Breast Cancers"

Researchers at Kings College London have developed a promising new antibody therapy targeting aggressive breast cancer, particularly beneficial for treatment-resistant cases and triple-negative breast cancer patients.

• The new antibody therapy, developed by scientists at Kings College London, targets aggressive breast cancer, offering hope for patients unresponsive to current treatments.
• This therapy aims to enhance the immune system response against neoplasm, specifically in cases of triple-negative breast cancer which lack crucial receptor (biochemistry) targets.
• Published in Cancer Research, the study highlights the potential of immunotherapy strategies in combating resistant forms of cancer, particularly for those affected by aggressive variants.